|
|
|
|
|
|
| Featured |
|
|
The Pharm Exec Podcast: Episode 2 |
In the second episode of the Pharm Exec podcast series, the editors speak with Marc O’Connor, COO at Curant Health and Pharm Exec’s Editor-in-Chief, Lisa Henderson with insights on the JPMorgan Healthcare Conference that took place at the beginning of January.
... /Read more/ |
|
|
|
|
| Advertisement |
A Molecule’s Journey - Breaking Down Roadblocks to Commercial Success
In this guidebook, our experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible without sacrificing product quality, process efficiency, or patient safety.
 Download the White Paper >>
|
|
| Industry Reputation |
 |
|
Engaging Patients, Engaging the Public
|
Pharm Exec speaks to Jane Griffiths, Global Head of Actelion, about the current state of the industry’s reputation and the work that needs to be done to further build trust with patients and the public.
... /Read more/ |
|
|
| Advertisement |
CRO Consolidation: A Sinister Threat or Windfall for Pharma?
Live Webcast: Tuesday, March 27 at 1:00pm EDT
 Register now
|
|
| Executive Profile |
 |
|
Valeant’s Northern Face |
In this Q&A, Richard Lajoie, the new head of Valeant Canada, shares his main priorities for the business, including growing its domestic manufacturing as a key cog globally.
... /Read more/ |
|
|
|
|
|
|
|
|
|
|
